Filing Details
- Accession Number:
- 0001213900-18-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-02 17:08:19
- Reporting Period:
- 2017-12-29
- Accepted Time:
- 2018-01-02 17:08:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1518520 | Icagen Inc. | NONE | Services-Commercial Physical & Biological Research (8731) | 200982060 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1624783 | Cunningham, Richard Anthony | C/O Icagen, Inc. 4222 Emperor Blvd., Suite 350, Research Triangle Park Durham, NC 27703 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2017-12-29 | 21,428 | $0.37 | 21,428 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant | Acquisiton | 2017-12-29 | 5,357 | $0.02 | 5,357 | $3.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,357 | 2017-12-29 | 2019-12-31 | No | 4 | A | Direct |
Billionaire Hedge Funds
